Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |